TWST:NASDAQ
Twist Bioscience Corp
US$ १४०.३३
arrow_upward
+०.४०%(+०.५६) 1D
अक्टोबर २०, १०:१०:१९ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
US$ १३९.७७
High
US$ १४०.८२
Low
US$ १३४.९४
Mkt. cap
९.३१ अरब
Avg. vol.
२८.३७ लाख
Volume
१.७३ लाख
52-wk high
US$ २१९.७१
52-wk low
US$ २३.३०
EPS
-US$ २.२२
Beta
२.१९
Shares outstanding
६.५८ करोड
No. of employees
९७९
Open
US$ १३९.७७
High
US$ १४०.८२
Low
US$ १३४.९४
Mkt. cap
९.३१ अरब
Avg. vol.
२८.३७ लाख
Volume
१.७३ लाख
52-wk high
US$ २१९.७१
52-wk low
US$ २३.३०
EPS
-US$ २.२२
Beta
२.१९
Shares outstanding
६.५८ करोड
No. of employees
९७९
News stories
From web sources and news partners
ad-hoc-news.de
·
१ घण्टा पहिले
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Simply Wall Street
·
५ घण्टा पहिले
Is Twist Bioscience (TWST) Too Rich Or Still Reasonable On Sales?
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp